A History of Outperforming Analyst Forecasts and Beating the Odds: Humana Inc. (HUM)

With 1.56 million shares changed hands, the volume of the stock remained lighter than its average volume of 2.08 million shares. During the session, the Healthcare Plans company that operates in wider Healthcare sector, reached to the highest price of $331.0 whereas the lowest price it dropped to was $324.055. The 52-week range on HUM shows that it touched its highest point at $541.21 and its lowest point at $299.23 during that stretch. It currently has a 1-year price target of $381.05. With its current market cap of 39.16 billion, HUM has annualized dividend of $3.54 while the current yield stands at 1.09%. Beta for the stock currently stands at 0.48.

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of HUM was up-trending over the past week, with a rise of 2.70%, but this was down by -7.61% over a month. Three-month performance dropped to -21.15% while six-month performance fell -37.52%. The stock lost -36.64% in the past year, while it has lost -29.05% so far this year. A look at the trailing 12-month EPS for HUM yields 19.83 with Next year EPS estimates of 23.00. For the next quarter, that number is 6.12. This implies an EPS growth rate of -37.33% for this year and 40.65% for next year. EPS is expected to grow by 2.23% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 10.46%.

Float and Shares Shorts:

At present, 122.22 million HUM shares are outstanding with a float of 120.12 million shares on hand for trading. On 2024-03-28, short shares totaled 2.45 million, which was 202.99999 higher than short shares on 1709164800. In addition to Mr. Bruce Dale Broussard as the firm’s CEO & Director, Ms. Susan Marie Diamond serves as its Chief Financial Officer.

Institutional Ownership:

Through their ownership of 0.93816 of HUM’s outstanding shares, institutional investors have minority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for HUM since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.